SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹4,567 Cr | ₹4,061 Cr | ₹3,647 Cr | ₹4,639 Cr | ₹4,909 Cr |
What is the latest Contingent Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹4,567 Cr |
Mar2023 | ₹4,061 Cr |
Mar2022 | ₹3,647 Cr |
Mar2021 | ₹4,639 Cr |
Mar2020 | ₹4,909 Cr |
How is Contingent Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4,567 Cr | 12.46 | |
Mar2023 | ₹4,061 Cr | 11.36 | |
Mar2022 | ₹3,647 Cr | -21.38 | |
Mar2021 | ₹4,639 Cr | -5.51 | |
Mar2020 | ₹4,909 Cr | - |
Compare Contingent Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹404,761.9 Cr | 0.5% | -0.5% | 14.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,468.0 Cr | 1.3% | 10.7% | 49.3% | Stock Analytics | |
CIPLA | ₹121,326.0 Cr | 2.2% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,757.0 Cr | 4.7% | 11.9% | 14.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,345.0 Cr | 2% | -0.8% | 15.7% | Stock Analytics | |
MANKIND PHARMA | ₹98,512.2 Cr | 0.7% | -6.7% | 10.3% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | 0.5% |
-0.5% |
14.6% |
SENSEX | 0.3% |
0.7% |
8.8% |
You may also like the below Video Courses